Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Star Equity Holdings, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
423
457
66.9
93.8
101
169
201
161
140
172
Cost of revenue
248
17.6
24.8
69.9
92.3
Gross profit
174
42.1
42.1
70.2
79.9
Selling and marketing
4.03
0.61
0.66
0.85
0.94
2.02
3.78
3.64
3.59
3.96
General and administrative
33.5
7.97
9.67
8.12
6.63
8.11
10.3
10.9
10.7
14.8
Operating expenses
182
43.9
72.1
95.5
104
165
192
160
74
83.6
Operating income
-7.59
-1.81
-5.22
-1.66
-2.65
4.39
9.34
1.38
-3.81
-3.69
Other non-operating income
-0.25
-0.16
-0.25
-0.34
0.46
-0.08
0.04
0.81
-0.02
-0.43
Pre-tax income
-8.19
-1.98
-5.17
-1.38
-0.71
4.34
9.46
2.57
-3.47
-3.86
Income tax
0.74
0.87
0.1
-0.54
0.54
1.12
2.33
0.37
1.3
2.06
Income from continuing operations
-8.93
-2.84
-5.27
-0.84
-1.24
Net income
-8.79
-2.94
7.87
-0.96
-1.24
3.23
7.13
2.2
-4.77
-5.92
EBITDA
-4.5
0.94
-4.52
-1.58
-2.47
4.99
10.7
2.85
-2.45
-1.61
EPS, basic
-2.59
-0.90
2.39
-0.30
-0.43
1.11
2.37
0.72
-1.59
-1.85
EPS, diluted
-2.59
-0.90
2.39
-0.30
-0.43
1.07
2.27
0.70
-1.59
-1.85
Shares, basic (weighted)
3.33
3.22
3.29
3.13
2.91
2.92
3.01
3.06
3
3.2
Shares, diluted (weighted)
3.33
3.22
3.29
3.13
2.91
3
3.14
3.14
3
3.2
Dividend per share
1.00
Balance sheet
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
21.3
5.58
40.6
31.2
25.8
21.7
27.1
22.6
17
10.3
Receivables
58.5
11.5
9.89
12.8
13.4
25.7
26.3
19.7
20.1
35.2
Inventory
0
6.99
Other current assets
4.27
0.39
0.67
0.8
0.89
1.48
1.96
3.17
2.56
4.17
Total current assets
84.1
97
52.1
44.9
40.3
49.2
55.5
45.8
40.1
62.5
Property, plant and equipment
7.04
0
0.17
0.19
0.12
0.37
0.67
0.42
0.24
18.6
Lease right-of-use assets
0
0.4
0.21
0.48
0.69
1.43
1.02
11.7
Goodwill
1.81
0
0
2.09
4.22
4.88
5.75
5.7
5.94
Intangible assets
0
1.4
5.49
4.52
3.63
2.49
1.69
Long-term investments
0
0.95
Other non-current assets
4.14
0.27
0.01
0.01
0
0.01
0.01
0.32
0.16
0.01
Total assets
102
112
53.2
46.7
45.4
61.2
67.9
61
52.6
113
Accounts payable
4.67
1.19
1.46
1.06
0.58
0.87
1.68
0.87
1.79
4.77
Accrued liabilities
36.2
7.26
8.98
8.18
4.44
6.75
6.35
4.64
4.38
6.91
Deferred revenue
0.13
1.5
Short-term debt
7.77
7.08
0
0.75
1.25
0
8.47
Total current liabilities
50.6
60.4
10.6
9.49
10
19.7
21.1
11.2
11.2
29.8
Long-term debt
0
1.25
0
0
6.06
Lease liabilities
0
0.16
0.02
0.12
0.35
0.66
0.44
11.2
Other non-current liabilities
4.17
0.19
0.15
0.18
0.19
0.4
0.6
0.44
0.4
0.31
Total liabilities
59.9
68.5
12.7
10.7
11.1
21.9
22.2
12.4
12.2
47.5
Total debt
0
1.25
0
6.06
Paid-in capital
482
484
485
486
487
489
492
493
494
530
Retained earnings
-440
-443
-436
-437
-438
-435
-427
-425
-430
-436
Treasury stock
-6.87
-7.73
-8.49
-13.1
-15.3
-15.3
-16.7
-17.9
-21.1
-27.1
Other comprehensive income
6.93
10.7
-0.61
-0.48
0.53
-0.09
-1.64
-1.29
-2.72
-1.36
Shareholders' equity
41.9
43.2
40.5
36
34.3
39.3
45.8
48.6
40.4
65.7
Total equity
41.9
43.2
40.5
36
34.3
39.3
45.8
48.6
40.4
65.7
Total liabilities and equity
102
112
53.2
46.7
45.4
61.2
67.9
61
52.6
113
Shares outstanding
3.13
3.19
2.94
2.69
2.82
2.79
2.81
2.75
3.76
Cash flow statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-8.79
-2.94
7.87
-0.96
-1.24
3.23
7.13
2.2
-4.77
-5.92
Depreciation and amortization
3.09
2.75
0.7
0.09
0.18
0.6
1.38
1.47
1.36
2.08
Stock-based compensation
1.45
1.29
1.54
0.96
0.74
2.42
2.32
1.47
1.28
1.5
Deferred income tax
-0.23
0.74
-0.55
-0.21
-0.17
-0.35
-0.23
-1.09
0.53
0.94
Change in receivables
-0.58
-7.81
-6.31
-2.94
0.67
-11.7
-2.13
6.92
-1.28
-2.59
Change in inventory
0
2.11
Change in payables
-3.32
7.27
-4.68
-2.5
-1.6
8.57
2.12
-6.65
0.56
-2.54
Cash from operations
-9.42
2.2
-15.5
-4.83
-1.43
2.51
9.45
0.32
-2.79
-7.26
Capital expenditures
-2.77
-1.47
-0.47
-0.08
-0.02
-0.28
-0.5
-0.1
-0.02
-1.7
Acquisitions
0
-4
-6.02
-0.83
-2.06
0
Purchases of investments
0
-1.54
Cash from investing
-2.72
-1.47
27.3
-0.08
-4.02
-6.3
-1.33
-2.15
1.06
4.57
Debt issued
0
11.4
Debt repaid
0
-10.9
Share buybacks
-5.13
-0.86
-0.21
-4.55
-2.24
0
-1.13
-0.96
-2.78
-2.64
Dividends paid
-3.4
0
Cash from financing
-2.93
-2.52
7.18
-4.59
-0.93
-0
-2.04
-2.45
-3.1
-1.96
Exchange rate effect
-1.27
1.28
0.06
0.16
0.85
-0.29
-0.72
-0.02
-0.67
0.39
Net change in cash
-16.3
-0.51
19.1
-9.34
-5.52
-4.09
5.36
-4.31
-5.5
-4.26
Free cash flow
-12.2
0.73
-16
-4.91
-1.45
2.22
8.95
0.22
-2.81
-8.96
Interest paid
0.34
0.4
0.09
0.01
0
0
0
0.38
Income taxes paid
0.92
2.01
0.16
0.65
1.11
1.46
3.03
2.19
0.46
1.9
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $10.17 on September 24, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
42.0%
Gross profit / revenue.
Operating margin
-3.4%
Operating income / revenue.
EBITDA margin
-1.8%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-3.5%
Pre-tax income / revenue.
Net margin
-4.3%
Net income / revenue.
FCF margin
-6.8%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-4.6%
Cash from operations / revenue.
Return on equity (ROE)
-15.2%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-8.4%
Net income / average total assets.
Return on invested capital (ROIC)
-9.7%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue
1.0%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
2.1%
Capital expenditures / revenue.
D&A / revenue
1.6%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
22.9%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-5.0%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
11.2%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y
13.9%
Gross profit vs the same period a year earlier. Only from a positive base.
Book value growth, 1y
62.5%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
12.8%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y
13.9%
Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
115.3%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
18.6%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
20.1%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
6.6%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
0.6%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
1.9%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
1.96x
Current assets / current liabilities.
Quick ratio
1.42x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.23x
(Cash + short-term investments) / current liabilities.
Debt / equity
0.09x
Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets
4.7%
Total debt / total assets.
Liabilities / assets
44.8%
Total liabilities / total assets.
Net debt
-$1.7M
Total debt - cash - short-term investments. Negative means more cash than debt.
Days inventory + days sales outstanding - days payables.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$2.46
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$56.63
Revenue / diluted weighted shares.
FCF per share
-$3.83
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$2.62
Cash from operations / diluted weighted shares.
Book value per share
$16.17
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
0.18x
Market cap / revenue.
P/B
0.63x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
0.71x
Market cap / tangible book value, when positive.
EV/Sales
0.17x
Enterprise value / revenue.
FCF yield
-37.8%
Free cash flow / market cap.
Earnings yield
-24.3%
Net income / market cap (the inverse of P/E).
Shareholder yield
9.3%
(Dividends paid + share buybacks) / market cap.
What was Star Equity Holdings, Inc.'s revenue in fiscal 2025?
Star Equity Holdings, Inc. reported revenue of $172.2M for fiscal 2025, 22.9% higher than the year before.
Was Star Equity Holdings, Inc. profitable in fiscal 2025?
No. It reported a net loss of $5.9M.
How much free cash flow did Star Equity Holdings, Inc. generate in fiscal 2025?
Cash from operations of $7.3M minus capital expenditures of $1.7M left free cash flow of -$9.0M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.